Stamford, CT -- (SBWIRE) -- 01/23/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Himax Technologies, Inc. (ADR) (NASDAQ:HIMX).
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) opened its last trade at the price of $1.10. Its closing price was $1.04 after losing -4.59% for the day. The company traded with the total volume of 11.69 million shares, while its average trading volume remained 11.41 million shares. The beta of this stock stands at 1.83. Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs.
Has RNN Found The Bottom and Ready To Move Up? Find Out Here
Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA) percentage change plunged -2.21% to close at $3.10 with the total traded volume of 14.49 million shares, along with average volume of 14.86 million shares. The 52 week range of the stock remained $0.27 - $5.44, while its day lowest price was $3.05. The share price hit the day highest price of $3.22. Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support services in the secondary mortgage market in the United States. The company securitizes mortgage loans originated by lenders in the primary mortgage market into Fannie Mae mortgage-backed securities (Fannie Mae MBS).
Has FNMA Found The Bottom And Ready To Gain Momentum? Find Out Here
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) traded on volume of 17.12 million shares in the last session against average volume of 29.50 million shares. The company started its trading session with the price of $6.59 and closed at $6.71 by scoring +1.67%. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Why Should Investors Buy ARIA After The Recent Gain? Just Go Here and Find Out
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) started its last trading session with the price of $14.20 and closed at $14.80 by scoring 7.01%. The stock traded with total volume of 16.23 million shares, while the average trading volume remained 8.30 million shares. The beta value of this stock stands at 1.73. Day range for the stock was $14.02 - $15.33. Himax Technologies, Inc. designs, develops, and markets semiconductors for flat panel displays. The company operates in two segments, Driver IC and Non-Driver Products. Its principal products include display drivers and timing controllers for large-sized thin film transistor liquid crystal display (TFT-LCD) panels that are used in desktop monitors, notebook computers, and televisions.
For How Long HIMX will Fight for Profitability? Read This Trend Analysis report
About Wall Street Pennies
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “http://www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by http://www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)